- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT06611618
Analyse des Verlusts von Muskelkraft, Muskelkraft und motorischer Kontrolle zur Vorhersage des Sturzrisikos bei Patienten mit Knie-Arthrose (PowerAGING)
Analysieren Sie die Kraft- und Muskelschwäche sowie den Abbau der motorischen Kontrolle durch die Vorstufe der Cadute in einer von Ginocchio beeinflussten Art
The twofold goal of this study is to understand the link between muscle power, muscle strength, and muscle control degradation with the risk of falling, and to develop a framework for the comprehensive and quantitative assessment of muscle power (and strength) in an elderly population of patients with knee osteoarthritis, who are at higher risk of falling. The main question it aims to answer is:
● Are muscle power and motor control degradation better predictors of falls than muscle strength in the aging population?
Participants will undergo:
- Muscle force assessment on a dynamometer
- Muscle power assessment on a dynamometer and on isntrumented stairs
- Home-based mobility monitoring
- Full lower limb MRI acquisition
- Gait assessment
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Falls are a critical yet common event among the elderly, with huge societal and economic impact (reduced quality of life and high costs for the healthcare system). Experimental measures to quantify the residual muscle strength and power may provide useful information to predict the risk of falls in the elderly. Isometric and isokinetic muscle contractions, performed on a dynamometer or during functional tasks can be collected, together with electromyography (to assess muscle activity) and imaging data (to quantify and characterize muscular tissue).
Such data can be collected at different time points to monitor subjects over time, and to inform virtual representation of the human musculoskeletal system (digital twins) to identify possible motor control deficits. Moreover, this same information can be used to better characterize/assess elder individuals at risk of falling (e.g., subjects with knee osteoarthritis), to prevent future falls.
All subjects enrolled in the PowerAGING study will be followed up for 24 months (5 visits in total: M0, M6, M12, M18 and M24 follow-up). At each visit, a series of experimental tests to quantify muscle power and muscle force, as well as a home-based mobility assessment (via single inertial sensor worn for 5 consecutive days), will be performed. In addition, only at start and end, the subjects will undergo a full lower limb MRI and a gait assessment.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Lisa Berti, Professor
- Telefonnummer: +390516366529
- E-Mail: lisa.berti@ior.it
Studieren Sie die Kontaktsicherung
- Name: Massimiliano Baleani, Engineer
- Telefonnummer: +390516366865
- E-Mail: massimiliano.baleani@ior.it
Studienorte
-
-
-
Bologna, Italien, 40136
- Rekrutierung
- IRCCS Istituto Ortopedico Rizzoli
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Age between 65 and 80 years
- Kellgren score II e III
- No history of falls in the last 12 months
Exclusion Criteria:
- Any musculoskeletal, neurological, rheumatic or tumoral diseases
- Dementia
- Diabetes
- Inguinal or abdominal hernia
- Severe Hypertension (Level 3)
- Severe Cardio-pulmonary insufficiency
- Diagnosis of Osteonecrosis in the lower limb joints
- Pathologies or physical conditions incompatible with the use of magnetic resonance imaging and electrostimulation (i.e., active and passive implanted biomedical devices, epilepsy, severe venous insufficiency in the lower limbs)
- Previous interventions or traumas to the joints of the lower limb
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Knee Osteoarthritis
Elderly patients with knee osteoarthritis, without a history of falls (in the 12 months prior to enrollment). All subjects will be followed up for 24 months, every 6 months. Muscle force and power assessments, plus a home-based mobility monitoring, will be performed at all visits. Full lower limb MRI and a gait assessment will be performed at first and last visit. |
Isokinetic dynamometry test Stair ascent/descent on instrumented stairs Isometric dynamometry (Maximal Voluntary Isometric Contraction) Mobility monitoring with wearable sensors Full lower limb MRI Motion capture, surface EMG and gorund reaction force data |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Maximal muscle force
Zeitfenster: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Maximal Isometric muscle force from dynamometry test |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle power
Zeitfenster: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Assessed on the dynamometer and during dynamic tasks |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle activations
Zeitfenster: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
From surface EMG data collected on the dynamometer and during dynamic tasks (gait assessment and stair ascent/descent) |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Digital Mobility Outcomes
Zeitfenster: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Qualitative and quantiative measures of real-world mobility (e.g., gait speed, stride length) |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Musculoskeletal model predictions
Zeitfenster: At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
Estimates of muscle force and knee joint contact forces |
At baseline (Day 0) and all follow-up visits (Month 6, Month 12, Month 18, Month 24)
|
|
Muscle volumes
Zeitfenster: From first follow-up visit (Month 6) to last follow-up visit (Month 24)
|
Estimation of muscle volumes (cm3) |
From first follow-up visit (Month 6) to last follow-up visit (Month 24)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Lisa Berti, Professor, IRCCS Istituto Ortopedico Rizzoli
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- CE-AVEC 204/2024/Sper/IOR
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .